/Investor DB

XEIA Venture Partners — 2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Vonovavonova.ioinJun 2025✓ verified

Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.

Deep TechHealthtechMedical Devices

José Morales(Dr.)

Co-investorsDevice of Tomorrow CapitalSmartGateVC

Coherence Neurocoherenceneuro.comin𝕏Nov 2025 · $10M

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.

AI & Machine LearningBiotechMedical DevicesSan Francisco, US

Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in

Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalEmpath VenturesIrregular Expressions+5 more

NeuroBionicsneurobionics.ioinNov 2025

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in

Co-investorsDevice of Tomorrow CapitalDolby Family VenturesEmpath VenturesFuture VenturesGreyMatterMana Ventures+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Forecast Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.